Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence and risk factors for recurrence of ampullary adenomas after endoscopic papillectomy: Comparative analysis of familial adenomatous polyposis and sporadic ampullary adenomas in an international multicenter cohort.
Singh AD, Burke CA, Draganov PV, Bapaye J, Nishimura M, Ngamruengphong S, Kushnir V, Sharma N, Kaul V, Singh A, Bapaye A, Banerjee D, Bayudan A, De Leon MR, Singh RR, Mony S, Gandhi A, Hollander T, Bittner K, Beauvais J, Lyu R, Liska D, Stevens T, Walsh M, Bhatt A. Singh AD, et al. Among authors: bittner k. Dig Endosc. 2023 Nov 20. doi: 10.1111/den.14725. Online ahead of print. Dig Endosc. 2023. PMID: 37985239
Rationale and design of an implant procedure and pivotal study to evaluate safety and effectiveness of Medtronic's tibial neuromodulation device.
Lee UJ, Xavier K, Benson K, Burgess K, Harris-Hicks JE, Simon R, Proctor JG, Bittner KC, Stolen KQ, Irwin CP, Offutt SJ, Miller AE, Michaud EM, Falkner PC, Coetzee JC. Lee UJ, et al. Among authors: bittner kc. Contemp Clin Trials Commun. 2023 Aug 22;35:101198. doi: 10.1016/j.conctc.2023.101198. eCollection 2023 Oct. Contemp Clin Trials Commun. 2023. PMID: 37691849 Free PMC article.
Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE study.
Goudelocke C, Xavier K, Pecha B, Burgess K, Perrouin-Verbe MA, Krlin R, Michaels J, Shah S, Peyronnet B, Zaslau S, Champs M, Papi B, Bittner K, Elterman D, Nitti V. Goudelocke C, et al. Among authors: bittner k. Neurourol Urodyn. 2023 Apr;42(4):761-769. doi: 10.1002/nau.25171. Epub 2023 Mar 14. Neurourol Urodyn. 2023. PMID: 36917003
Prospective, multicenter study to evaluate performance and safety of a re-engineered temporary lead for InterStim™ therapy evaluation.
Elterman D, Michaels J, Margolis E, Harris-Hicks J, Burgess K, Betts C, Harding C, Towers G, Hashim H, Ojo-Carons A, White A, Cannon-Smith T, Grunow N, Bittner K, Xavier K. Elterman D, et al. Among authors: bittner k. Neurourol Urodyn. 2022 Nov;41(8):1731-1738. doi: 10.1002/nau.24987. Epub 2022 Jul 28. Neurourol Urodyn. 2022. PMID: 35900298
144 results